Related Science News

March 5, 2025

ORNL research helps cut cancer pathology reporting time

In a major milestone for cancer research, the Department of Energy’s Oak Ridge National Laboratory helped reduce the time between cancer diagnosis and pathology report processing from 22 months to just 14 months, utilizing advanced artificial intelligence technology developed by ORNL's research team. This significant step forward, announced by the […]
February 26, 2025

Unraveling the Mysteries of DNA Damage in the Brain

Understanding how neurons repair genomic errors in DNA sheds light on aging and neurodegenerative disease progression. Brain cells receive sensory inputs from the outside world and send signals throughout the body telling organs and muscles what to do. Although neurons comprise only 10% of brain cells, their functional and genomic […]
February 11, 2025

The Link Between Hearing Loss and Cognitive Decline

Over the past few decades, a growing body of research has revealed an association between hearing loss and cognitive decline in older adults. Studies have found that individuals with hearing loss are more likely to develop dementia and experience faster rates of cognitive decline over time compared to those with […]
January 28, 2025

Study finds fluoride in water does not affect brain development

A University of Queensland study has found no link between exposure to water fluoridation as a young child and negative cognitive development. Professor Loc Do from UQ’s School of Dentistry said the IQ scores of 357 people who had participated in the 2012–2014 National Child Oral Health Study were assessed […]
January 22, 2025

Novel ultrasound treatment for Alzheimer's licensed to new startup

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer's disease has been licenced to a new startup spun out of The University of Queensland. The therapeutic ultrasound technology developed by Professor Jürgen Götz from UQ’s Queensland Brain Institute will be progressed toward clinical use by Ceretas, […]
December 29, 2024

Challenge: Point-of-care test for latent tuberculosis detection

NineSigma’s client is a leading global pharmaceutical company at the forefront of state-of-the-art biopharmaceutical research and innovation. As part of their innovation pursuits, they are launching a novel new treatment for Psoriasis, a chronic autoimmune disease that impacts over 125 million individuals globally. Psoriasis is characterized by red, scaly patches of […]